Trial Profile
Study of motor-evoked potentials (MEP) by an increased central motor conduction time (CMCT) as a predicative therapeutic response marker for oral fampridine
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Dec 2015
Price :
$35
*
At a glance
- Drugs Fampridine (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- 03 Dec 2015 New trial record